HMGB1 and cancer: As a significant mediator of both acute and chronic inflammation, HMGB1 is implicated in the onset and progression of numerous conditions, including systemic lupus erythematosus, myositis, sepsis, trauma, respiratory disorders, myocardial infarction, atherosclerosis, cancer and cerebral diseases [14, 15, 16].